Figure S7. Immunoreactivity for COL6A2 is equally present in leptomeningeal vessels in control, AD and CAA tissue. (TIF 3794 kb
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S4. Pathway analysis of proteins differentially increased in 5xFAD (vs. WT) microglia. (XLSX 1...
Figure S1. Coomassie blue staining of the SDS PAGE gels containing the microdissected tissue lysates...
Figure S4. Clustering analysis of experimental groups and individual cases. Clustering analysis and ...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Figure S6. Protein expression of males versus females. Quantitative data on several CAA selective da...
Abstract Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) deposits as plaques in the p...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Figure S6. Cell Type Population Changes Associated with AD and Correlation with Amyloid and Tau Path...
High magnification of an amyloid plaque surrounded by GPNMB-positive microglia. (PDF 481 kb
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Correlation analysis between GPNMB gene expression levels and microglia markers measured by RT-PCR. ...
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S4. Pathway analysis of proteins differentially increased in 5xFAD (vs. WT) microglia. (XLSX 1...
Figure S1. Coomassie blue staining of the SDS PAGE gels containing the microdissected tissue lysates...
Figure S4. Clustering analysis of experimental groups and individual cases. Clustering analysis and ...
Figure S2. Total protein fluorescent signal from blots used for immunoblot analysis. Total protein l...
Figure S6. Protein expression of males versus females. Quantitative data on several CAA selective da...
Abstract Alzheimer’s disease (AD) is characterized by amyloid beta (Aβ) deposits as plaques in the p...
Figure S1. SDS-PAGE of Brain Homogenates. Dorsolateral prefrontal cortex (DLPFC) brain tissue homoge...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Figure S6. Cell Type Population Changes Associated with AD and Correlation with Amyloid and Tau Path...
High magnification of an amyloid plaque surrounded by GPNMB-positive microglia. (PDF 481 kb
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Correlation analysis between GPNMB gene expression levels and microglia markers measured by RT-PCR. ...
Table S3. List of novel proteins with altered abundances in AD identified in the present study. The ...
Table S1. Log2 transformed protein abundance data and differential expression analyses. (XLSX 1522 k...
Table S4. Pathway analysis of proteins differentially increased in 5xFAD (vs. WT) microglia. (XLSX 1...